ZA201901592B - Recombinant binding proteins and their use - Google Patents

Recombinant binding proteins and their use

Info

Publication number
ZA201901592B
ZA201901592B ZA2019/01592A ZA201901592A ZA201901592B ZA 201901592 B ZA201901592 B ZA 201901592B ZA 2019/01592 A ZA2019/01592 A ZA 2019/01592A ZA 201901592 A ZA201901592 A ZA 201901592A ZA 201901592 B ZA201901592 B ZA 201901592B
Authority
ZA
South Africa
Prior art keywords
binding proteins
recombinant binding
recombinant
proteins
binding
Prior art date
Application number
ZA2019/01592A
Other languages
English (en)
Inventor
Metz Clara
Fiedler Ulrike
DOLADO Ignacio
Maria STROBEL Heike
Original Assignee
Molecular Partners Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Partners Ag filed Critical Molecular Partners Ag
Publication of ZA201901592B publication Critical patent/ZA201901592B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2019/01592A 2016-09-22 2019-03-14 Recombinant binding proteins and their use ZA201901592B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16190221 2016-09-22
PCT/EP2017/073768 WO2018054971A1 (en) 2016-09-22 2017-09-20 Recombinant binding proteins and their use

Publications (1)

Publication Number Publication Date
ZA201901592B true ZA201901592B (en) 2021-04-28

Family

ID=57046984

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2019/01592A ZA201901592B (en) 2016-09-22 2019-03-14 Recombinant binding proteins and their use

Country Status (20)

Country Link
US (2) US10717772B2 (enExample)
EP (1) EP3515933B9 (enExample)
JP (1) JP6976335B2 (enExample)
KR (1) KR102270315B1 (enExample)
CN (1) CN109790206A (enExample)
AR (1) AR109680A1 (enExample)
AU (1) AU2017331329B2 (enExample)
BR (1) BR112019005587A2 (enExample)
CA (1) CA3036301C (enExample)
CL (1) CL2019000729A1 (enExample)
CO (1) CO2019002609A2 (enExample)
ES (1) ES2953516T3 (enExample)
IL (1) IL265489B (enExample)
MX (1) MX377424B (enExample)
MY (1) MY196882A (enExample)
NZ (1) NZ751689A (enExample)
PH (1) PH12019500596B1 (enExample)
SA (1) SA519401369B1 (enExample)
WO (1) WO2018054971A1 (enExample)
ZA (1) ZA201901592B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020286600A1 (en) * 2019-06-04 2021-12-23 Molecular Partners Ag Recombinant FAP binding proteins and their use
AU2020289080A1 (en) * 2019-06-04 2021-12-23 Molecular Partners Ag Multispecific proteins
EP3980452A1 (en) * 2019-06-04 2022-04-13 Molecular Partners AG Recombinant 4-1bb binding proteins and their use
CA3138805A1 (en) 2019-06-04 2020-12-10 Johannes Schilling Designed ankyrin repeat domain with improved stability
CN114929730A (zh) 2019-12-11 2022-08-19 分子合作伙伴股份公司 重组肽-mhc复合物结合蛋白及其生成和用途
MX2022013945A (es) * 2020-05-06 2023-02-14 Molecular Partners Ag Nuevas proteinas de union a repeticiones de anquirina y sus usos.
JP2023528204A (ja) 2020-05-14 2023-07-04 モレキュラー パートナーズ アクチェンゲゼルシャフト 多選択性タンパク質
US20240279309A1 (en) * 2020-05-14 2024-08-22 Molecular Partners Ag Recombinant cd40 binding proteins and their use
WO2022130300A1 (en) 2020-12-16 2022-06-23 Molecular Partners Ag Novel slow-release prodrugs
JP2024509904A (ja) 2021-03-09 2024-03-05 モレキュラー パートナーズ アクチェンゲゼルシャフト 新規なDARPinに基づく多重特異性T細胞エンゲージャ
US20240156980A1 (en) 2021-03-09 2024-05-16 Molecular Partners Ag Protease cleavable prodrugs
EP4304730A1 (en) 2021-03-09 2024-01-17 Molecular Partners AG Novel darpin based cd33 engagers
AU2022233791A1 (en) 2021-03-09 2023-09-28 Molecular Partners Ag Novel darpin based cd123 engagers
IL313411A (en) 2021-12-14 2024-08-01 Molecular Partners Ag Designed repeat domains with dual binding specificity and their use
CN119731200A (zh) 2022-08-01 2025-03-28 分子合作伙伴股份公司 经电荷修饰设计的重复结构域及其用途
WO2024038307A1 (en) 2022-08-19 2024-02-22 Novartis Ag Dosing regimens for sars-cov-2 binding molecules
EP4665755A1 (en) 2023-02-17 2025-12-24 Ablynx N.V. Polypeptides binding to the neonatal fc receptor
WO2024179981A1 (en) 2023-02-27 2024-09-06 Molecular Partners Ag Darpins for use in reducing renal accumulation of drugs
WO2024251628A1 (en) 2023-06-06 2024-12-12 Molecular Partners Ag Recombinant cd16a binding proteins and their use
CN121263440A (zh) 2023-06-06 2026-01-02 分子合作伙伴股份公司 重组cd2结合蛋白及其用途
WO2025146487A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Multispecific binding proteins
WO2025146491A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
WO2025163144A1 (en) 2024-01-31 2025-08-07 Molecular Partners Ag Recombinant mesothelin binding proteins and their use
WO2025181039A1 (en) 2024-03-01 2025-09-04 Molecular Partners Ag Therapeutic combinations comprising a multi-specific t cell engager
WO2026013280A1 (en) * 2024-07-11 2026-01-15 Johann Wolfgang Goethe-Universität Frankfurt am Main Designed ankyrin repeat proteins binding p53, and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US7371376B1 (en) 1996-10-18 2008-05-13 Genentech, Inc. Anti-ErbB2 antibodies
CA2421447C (en) 2000-09-08 2012-05-08 Universitat Zurich Collections of repeat proteins comprising repeat modules
PT1567641E (pt) * 2001-08-24 2012-08-21 Uvic Industry Partnerships Inc Proaerolisina contendo sequência de activação de proteases e métodos de uso para o tratamento do cancro da próstata
CN101875919A (zh) 2004-11-12 2010-11-03 拜耳先灵医药股份有限公司 重组新城疫病毒
RU2412249C2 (ru) 2005-07-08 2011-02-20 Юниверсити Оф Цюрих Фаговый дисплей с применением котрансляционной транслокации слитых полипептидов
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
CN101970490A (zh) 2007-11-27 2011-02-09 埃博灵克斯股份有限公司 针对异二聚体细胞因子和/或其受体的氨基酸序列以及包括所述氨基酸序列的多肽
EP2358746B1 (en) 2008-11-03 2020-09-16 Molecular Partners AG Binding proteins inhibiting the vegf-a receptor interaction
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
EP2643349B1 (en) * 2010-11-26 2019-09-04 Molecular Partners AG Designed repeat proteins binding to serum albumin
KR20140039203A (ko) 2011-04-29 2014-04-01 얀센 바이오테크 인코포레이티드 Il4/il13 결합 반복 단백질 및 용도
WO2014001442A1 (en) 2012-06-28 2014-01-03 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
JP2015532306A (ja) * 2012-10-15 2015-11-09 チューリッヒ大学 癌治療のための二重特異性her2リガンド
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
US11453708B2 (en) 2013-05-31 2022-09-27 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
US9458211B1 (en) * 2015-04-02 2016-10-04 Molecular Partners Ag Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains

Also Published As

Publication number Publication date
EP3515933B1 (en) 2023-06-07
US20180155402A1 (en) 2018-06-07
CA3036301A1 (en) 2018-03-29
PH12019500596A1 (en) 2019-07-29
AU2017331329B2 (en) 2020-10-29
CO2019002609A2 (es) 2019-05-31
SA519401369B1 (ar) 2022-12-22
EP3515933C0 (en) 2023-06-07
AR109680A1 (es) 2019-01-09
BR112019005587A2 (pt) 2019-06-11
KR102270315B1 (ko) 2021-06-29
IL265489A (en) 2019-05-30
CA3036301C (en) 2021-04-20
RU2019111628A (ru) 2020-10-19
MY196882A (en) 2023-05-08
EP3515933A1 (en) 2019-07-31
WO2018054971A1 (en) 2018-03-29
CL2019000729A1 (es) 2019-06-14
EP3515933B9 (en) 2023-08-16
JP6976335B2 (ja) 2021-12-08
NZ751689A (en) 2021-07-30
IL265489B (en) 2021-07-29
PH12019500596B1 (en) 2024-02-21
US20210130420A1 (en) 2021-05-06
AU2017331329A1 (en) 2019-04-04
JP2019531093A (ja) 2019-10-31
KR20190050802A (ko) 2019-05-13
RU2019111628A3 (enExample) 2020-10-30
ES2953516T3 (es) 2023-11-14
MX377424B (es) 2025-03-10
MX2019003298A (es) 2019-09-26
US10717772B2 (en) 2020-07-21
CN109790206A (zh) 2019-05-21

Similar Documents

Publication Publication Date Title
IL265489B (en) Recombinant binding proteins and their uses
IL282704A (en) De novo binding domain containing polypeptides and uses thereof
ZA201808160B (en) Bispecific binding proteins and uses thereof
IL261666A (en) Related proteins and methods of using them
SMT202600071T1 (it) Proteine leganti l'antigene anti-tl 1a e relativi usi
IL287291A (en) A protein that binds to rgma and its use
IL262241A (en) Trispecific and/or trivalent binding proteins
IL246921A0 (en) Binding proteins and their uses
ZA201900209B (en) Novel natural protein and application thereof
EP3315513A4 (en) Cd154 binding polypeptide and use thereof
IL259519B (en) cd131 binding proteins and their uses
IL258863A (en) Integrin-binding peptides and their use
GB201707248D0 (en) Modified complement proteins and uses thereof
IL272050B1 (en) Synthetic proteins and their therapeutic uses
ZA201901862B (en) Modified factor h binding protein
ZA202006103B (en) Trispecific and/or trivalent binding proteins
PL3630967T3 (pl) Proteaza i polipeptyd wiążący dla o-glikoprotein
IL269477A (en) Polypeptides that bind to IL-1R-1
IL267565A (en) Binding polypeptides and methods for their preparation
EP3268042C0 (en) COMPOSITION CONTAINING AN ANTI-TNF-ALPHA POLYPEPTIDE AND USE
HUP1700012A2 (en) Novel proteins and use thereof
GB201607979D0 (en) Monomeric proteins and uses thereof
ZA201806629B (en) Trispecific and/or trivalent binding proteins
GB201617925D0 (en) Proteins and uses
AU2015904924A0 (en) Cd131 binding proteins and uses thereof